You are currently viewing a new version of our website. To view the old version click .

Drug–Drug and Drug–Natural Compound Interactions: From Bench to Bedside

This special issue belongs to the section “Pharmaceutical Science“.

Special Issue Information

Dear Colleagues,

To reduce the adverse effect and enhance the treatment efficacy, a series of drug combination is frequently applied for treatment of metabolic syndrome and cancers. Moreover, patients with metabolic syndrome or cancers usually take herbal supplements for remission of symptoms. Several studies observed that combination of the chemotherapeutic drugs or drug/natural compounds has additional therapeutic efficacies than drug or natural compounds alone. However, several studies also demonstrated that patients receiving drug/drug combination or drug/natural compounds combination experience unexpected adverse effects whereas which underlying mechanism is still elusive. This Special Issue intends to collect any studies, including research articles for evaluating new synergistic combination and their synergistic mechanisms, systemic reviews for evaluating potential drug/drug toxicity, or clinical trials for assessing the putative populations experiencing drug/drug synergism or toxicities.

Dr. Shian-Ren Lin
Prof. Dr. Ju-Seop Kang
Prof. Dr. Paola Nieri
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Life is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • synergism
  • drug interaction
Graphical abstract

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Published Papers

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Life - ISSN 2075-1729